Galectins in immune and inflammatory diseases

Insights from experiments with galectin deficient mice

Daniel K. Hsu, Ri Yao Yang, Agnes Fermin, Fu-Tong Liu

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Defining the properties of the multifunctional galectin family are particularly challenging, but has been facilitated by the creation of transgenic animals. In these respects, functions of broadly studied galectin-1, -3, and -9, have advanced considerably as a result of close examinations of knockout mice. While the pro-apoptotic properties of extracellular galectin-1 and -9 were determined in vitro, the spectrum of their regulatory functions in T helper cell influence was revealed by studies in galectin-1 and galectin-9 knockout (ko) mice. Both galectins were found to suppress Th1 and Th17 function by killing of these Th cells. Thus, they are both potential therapeutic agents for immune and inflammatory diseases. The functions of galectin-3 in several disease models have been explored and this protein appears to serve a pro-inflammatory role, predominantly by promoting cytokine production and infiltration of inflammatory cells, as well as prolonging inflammatory cell survival. The properties of galectin-3 as a promoter of fibrosis were confirmed as well in multiple disease models mediated by inflammatory changes. These studies support selection of galectin-3 as a therapeutic target of immune and inflammatory diseases.

Original languageEnglish (US)
Title of host publicationACS Symposium Series
PublisherAmerican Chemical Society
Pages343-358
Number of pages16
Volume1115
ISBN (Print)9780841228801
DOIs
StatePublished - Dec 18 2012

Publication series

NameACS Symposium Series
Volume1115
ISSN (Print)00976156
ISSN (Electronic)19475918

Fingerprint

Galectins
Galectin 1
Galectin 3
Experiments
Cells
Infiltration
Animals
Cytokines
Proteins

ASJC Scopus subject areas

  • Chemistry(all)
  • Chemical Engineering(all)

Cite this

Hsu, D. K., Yang, R. Y., Fermin, A., & Liu, F-T. (2012). Galectins in immune and inflammatory diseases: Insights from experiments with galectin deficient mice. In ACS Symposium Series (Vol. 1115, pp. 343-358). (ACS Symposium Series; Vol. 1115). American Chemical Society. https://doi.org/10.1021/bk-2012-1115.ch020

Galectins in immune and inflammatory diseases : Insights from experiments with galectin deficient mice. / Hsu, Daniel K.; Yang, Ri Yao; Fermin, Agnes; Liu, Fu-Tong.

ACS Symposium Series. Vol. 1115 American Chemical Society, 2012. p. 343-358 (ACS Symposium Series; Vol. 1115).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Hsu, DK, Yang, RY, Fermin, A & Liu, F-T 2012, Galectins in immune and inflammatory diseases: Insights from experiments with galectin deficient mice. in ACS Symposium Series. vol. 1115, ACS Symposium Series, vol. 1115, American Chemical Society, pp. 343-358. https://doi.org/10.1021/bk-2012-1115.ch020
Hsu DK, Yang RY, Fermin A, Liu F-T. Galectins in immune and inflammatory diseases: Insights from experiments with galectin deficient mice. In ACS Symposium Series. Vol. 1115. American Chemical Society. 2012. p. 343-358. (ACS Symposium Series). https://doi.org/10.1021/bk-2012-1115.ch020
Hsu, Daniel K. ; Yang, Ri Yao ; Fermin, Agnes ; Liu, Fu-Tong. / Galectins in immune and inflammatory diseases : Insights from experiments with galectin deficient mice. ACS Symposium Series. Vol. 1115 American Chemical Society, 2012. pp. 343-358 (ACS Symposium Series).
@inproceedings{4d30f2f572924c2da2a4cd9182f056dc,
title = "Galectins in immune and inflammatory diseases: Insights from experiments with galectin deficient mice",
abstract = "Defining the properties of the multifunctional galectin family are particularly challenging, but has been facilitated by the creation of transgenic animals. In these respects, functions of broadly studied galectin-1, -3, and -9, have advanced considerably as a result of close examinations of knockout mice. While the pro-apoptotic properties of extracellular galectin-1 and -9 were determined in vitro, the spectrum of their regulatory functions in T helper cell influence was revealed by studies in galectin-1 and galectin-9 knockout (ko) mice. Both galectins were found to suppress Th1 and Th17 function by killing of these Th cells. Thus, they are both potential therapeutic agents for immune and inflammatory diseases. The functions of galectin-3 in several disease models have been explored and this protein appears to serve a pro-inflammatory role, predominantly by promoting cytokine production and infiltration of inflammatory cells, as well as prolonging inflammatory cell survival. The properties of galectin-3 as a promoter of fibrosis were confirmed as well in multiple disease models mediated by inflammatory changes. These studies support selection of galectin-3 as a therapeutic target of immune and inflammatory diseases.",
author = "Hsu, {Daniel K.} and Yang, {Ri Yao} and Agnes Fermin and Fu-Tong Liu",
year = "2012",
month = "12",
day = "18",
doi = "10.1021/bk-2012-1115.ch020",
language = "English (US)",
isbn = "9780841228801",
volume = "1115",
series = "ACS Symposium Series",
publisher = "American Chemical Society",
pages = "343--358",
booktitle = "ACS Symposium Series",

}

TY - GEN

T1 - Galectins in immune and inflammatory diseases

T2 - Insights from experiments with galectin deficient mice

AU - Hsu, Daniel K.

AU - Yang, Ri Yao

AU - Fermin, Agnes

AU - Liu, Fu-Tong

PY - 2012/12/18

Y1 - 2012/12/18

N2 - Defining the properties of the multifunctional galectin family are particularly challenging, but has been facilitated by the creation of transgenic animals. In these respects, functions of broadly studied galectin-1, -3, and -9, have advanced considerably as a result of close examinations of knockout mice. While the pro-apoptotic properties of extracellular galectin-1 and -9 were determined in vitro, the spectrum of their regulatory functions in T helper cell influence was revealed by studies in galectin-1 and galectin-9 knockout (ko) mice. Both galectins were found to suppress Th1 and Th17 function by killing of these Th cells. Thus, they are both potential therapeutic agents for immune and inflammatory diseases. The functions of galectin-3 in several disease models have been explored and this protein appears to serve a pro-inflammatory role, predominantly by promoting cytokine production and infiltration of inflammatory cells, as well as prolonging inflammatory cell survival. The properties of galectin-3 as a promoter of fibrosis were confirmed as well in multiple disease models mediated by inflammatory changes. These studies support selection of galectin-3 as a therapeutic target of immune and inflammatory diseases.

AB - Defining the properties of the multifunctional galectin family are particularly challenging, but has been facilitated by the creation of transgenic animals. In these respects, functions of broadly studied galectin-1, -3, and -9, have advanced considerably as a result of close examinations of knockout mice. While the pro-apoptotic properties of extracellular galectin-1 and -9 were determined in vitro, the spectrum of their regulatory functions in T helper cell influence was revealed by studies in galectin-1 and galectin-9 knockout (ko) mice. Both galectins were found to suppress Th1 and Th17 function by killing of these Th cells. Thus, they are both potential therapeutic agents for immune and inflammatory diseases. The functions of galectin-3 in several disease models have been explored and this protein appears to serve a pro-inflammatory role, predominantly by promoting cytokine production and infiltration of inflammatory cells, as well as prolonging inflammatory cell survival. The properties of galectin-3 as a promoter of fibrosis were confirmed as well in multiple disease models mediated by inflammatory changes. These studies support selection of galectin-3 as a therapeutic target of immune and inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=84905216140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905216140&partnerID=8YFLogxK

U2 - 10.1021/bk-2012-1115.ch020

DO - 10.1021/bk-2012-1115.ch020

M3 - Conference contribution

SN - 9780841228801

VL - 1115

T3 - ACS Symposium Series

SP - 343

EP - 358

BT - ACS Symposium Series

PB - American Chemical Society

ER -